Issue Code: MED
1,726
466
289
2025--2026
7 activities
CORNERSTONE GOVERNMENT AFFAIRS, INC.
116 activities
VAN SCOYOC ASSOCIATES
40 activities
BALLARD PARTNERS
39 activities
POWERS PYLES SUTTER & VERVILLE, P.C.
36 activities
THE CONAFAY GROUP, LLC
35 activities
ALSTON & BIRD LLP
31 activities
DLA PIPER LLP (US)
31 activities
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
28 activities
FORBES-TATE
27 activities
CHECKMATE GOVERNMENT RELATIONS
25 activities
HOUSE OF REPRESENTATIVES
1,319 mentionsSENATE
1,309 mentionsHealth & Human Services, Dept of (HHS)
361 mentionsNatl Institutes of Health (NIH)
150 mentionsFood & Drug Administration (FDA)
142 mentionsCenters For Medicare and Medicaid Services (CMS)
135 mentionsDefense, Dept of (DOD)
122 mentionsWhite House Office
86 mentionsCenters For Disease Control & Prevention (CDC)
75 mentionsHealth Resources & Services Administration (HRSA)
61 mentions23ANDME RESEARCH INSTITUTE
via BALLARD PARTNERS
Government grants, FDA classification, and NIH genomics policy.
DJP SOVEREIGNTY ADVISORS
via DJP SOVEREIGNTY ADVISORS
Proposals, amendments, and federal initiatives relating to domestic manufacturing, supply chain resiliency, and technological sovereignty under the CHIPS and Science Act framework. Executive branch and legislative actions concerning federal tax credits, domestic sourcing, and Foreign Entity of Concern (FEOC) compliance mitigation. Specific provisions related to the STRIDE Act (CHIPS 2.0), regarding National Thermal Shield Deployment, advanced technology supply chain corridors, and FEOC mitigation strategies utilizing international trade manufacturing stacks. Public policy and regulatory frameworks impacting healthcare delivery networks, pharmaceutical development, biotechnology, and corporate financial compliance.
HSS | HOSPITAL FOR SPECIAL SURGERY
via HSS | HOSPITAL FOR SPECIAL SURGERY
Medicare reimbursement of tele-physical therapy; site-neutral payment policy; price/value transparency; application of AI to healthcare; health care privacy and cybersecurity; tax exempt status of nonprofit hospitals; physician-owned hospital policy
BROAD INSTITUTE INC.
via BROAD INSTITUTE INC.
- General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. Fiscal Year 2027 National Defense Authorization Act (NDAA) and Fiscal Year 2027 Defense Appropriations. Federal policies and investments related to data infrastructure and artificial intelligence for biomedical research, including standards for secure and scalable data ecosystems.
PKX BIO
via THE CONAFAY GROUP, LLC
Advocate for funding for research and development.
BRIOTECH INC
via ATLAS ADVOCACY
FDA requirements
CRESILON, INC.
via THE CONAFAY GROUP, LLC
Support for hemostatic technology research and the manufacturing of hemostatic products.
SANA HEALTH
via TERRAPIN STRATEGY, INC
General Introductions
SAFT AMERICA
via BLUE TUSK COMMUNICATIONS
Met with members and staff to discuss issues surrounding database creation.
RED ONE MEDICAL
via BLUE TUSK COMMUNICATIONS
Worked with members of Congress and staff discussing issues related to medical procurement.